Intersect ENT, Inc.
Surgical & Medical Instruments & Apparatus · 1555 ADAMS DRIVE, MENLO PARK, CA 94025
官方登記資料
0位追蹤者
2003成立於
關於 Intersect ENT, Inc.
Intersect ENT, a subsidiary of Medtronic, is a health care equipment company based in Menlo Park, California. It manufactures drug-delivery devices used by Ear, Nose & Throat (ENT) clinicians in the treatment of sinusitis. Intersect ENT is best known for developing the first bioabsorbable drug-eluting sinus stent PROPEL, which delivers anti-inflammatory medication directly to the sinuses. The company holds over 20 issued patents in the United States and more than 80 patents and patent applications worldwide. The company was named on the Forbes list of America's Most Promising Companies and was also on the Fierce 15 list of Most Promising Companies in 2013.
Source: Wikipedia
產業Surgical & Medical Instruments & Apparatus
總部1555 ADAMS DRIVE, MENLO PARK, CA 94025
成立時間2003
法律形式C Corporation
狀態營運中
專利141 項專利
Systems, devices, and method for treating a sinus conditionUS12551672B2 · 2026
SUBMUCOSAL BIORESORBABLE DRUG ELUTING PLATFORMUS2025352777A1 · 2025
關鍵數據
法律資訊
| 法定名稱 | Intersect ENT, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1271214在 SEC EDGAR 上查看 ↗ |
| EIN | 20-0280837 |
| 產業代碼(SIC) | 3841 |
| 登記地址 | 1555 ADAMS DRIVE, MENLO PARK, CA 94025 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日